We partner with the media to inform the public of the global human crisis.
January 11, 2018JP Morgan Healthcare Conference Presentation - Strengthening Our Global Leadership in Treatment of Addiction...
January 3, 2018Indivior and Addex Enter Strategic Collaboration to Accelerate Development of GABAB PAMs for Addiction Disorder Treatments...
December 19, 2017Indivior Announces Repricing and Maturity Extension of Term Loan Facilities and Replacement of Credit Facility...
December 12, 2017Indivior Announces NDA Acceptance of RBP-7000 Risperidone Monthly Depot...
November 30, 2017FDA Approves SUBLOCADE™ (Buprenorphine Extended-Release), the First and Only Once-Monthly Injectable Buprenorphine Formulation to Treat Moderate to Severe Opioid Use Disorder...
Global Media Contacts
EMEA, Australasia and China Financial Disclosure Reporting
Disclosure Of Payments, Donations & Joint Working
The Online Press Kit is designed to help media research our company for background information or follow-up stories. Please visit the links below to learn more.
About Indivior PLC – An overview of Indivior, including our worldwide locations and key products
Board of Directors – Biographies of Indivior’s Board
The Indivior PLC Pipeline – Information about the Indivior R&D efforts and progress of medicines in the pipeline